Long COVID clinical evaluation, research and impact on society: a global expert consensus

Andrew G. Ewing, David Joffe, Svetlana Blitshteyn, et. al. Annals of Clinical Microbiology and Antimicrobials volume 24, Article number: 27 (2025)  Abstract Background Long COVID is a complex, heterogeneous syndrome affecting over four hundred million people globally. There…[...]

Read More

🧠 Long COVID and Sleep Disorders: Mechanisms, Brain Centers, and Therapeutic Advances (2025 Review)

Sleep disturbances have emerged as one of the most persistent and disruptive symptoms of Long COVID, affecting up to 40–76% of patients months after infection2. This article synthesizes 2025 peer-reviewed…[...]

Read More

Hyperglycemia in Severe and Critical COVID-19 Patients: Risk Factors and Outcomes

Viet Tran Le • Quoc Hung Ha • Minh Triet Tran • Ngoc Trong Le • et. al., DOI: 10.7759/cureus.27611  Abstract Background: Hyperglycemia is commonly seen in critically ill patients. This disorder was also seen in coronavirus disease 2019…[...]

Read More

🧪 COVID Spike Protein and Kidney Damage: Stage 3B Illness, Fluid Retention, and Electrolyte Recovery

As research into Long COVID and post-vaccination syndromes deepens, 2025 peer-reviewed studies have identified a troubling link between spike protein persistence and kidney damage, particularly in patients progressing to Stage…[...]

Read More

🩺 COVID-19 Vaccination and Vasculitis of the Hands and Arms: A 2025 Peer-Reviewed Overview

As global vaccination efforts continue, rare autoimmune phenomena such as vasculitis of the hands and arms have emerged as important clinical considerations. This article synthesizes findings from 10 peer-reviewed studies…[...]

Read More